Regulation of reverse cholesterol transport - a comprehensive appraisal of available animal studies

被引:71
作者
Annema, Wijtske [1 ,2 ]
Tietge, Uwe J. F. [1 ,2 ]
机构
[1] Univ Groningen, Dept Pediat, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, NL-9700 AB Groningen, Netherlands
[2] Top Inst Food & Nutr, Wageningen, Netherlands
来源
NUTRITION & METABOLISM | 2012年 / 9卷
关键词
Atherosclerosis; Bile; Cholesterol; Efflux; Feces; High density lipoproteins; Intestine; Liver; Macrophages; reverse cholesterol transport; HIGH-DENSITY-LIPOPROTEIN; LIVER-X-RECEPTOR; ESTER TRANSFER PROTEIN; APOLIPOPROTEIN-A-I; BILIARY STEROL SECRETION; CORONARY-HEART-DISEASE; ATHEROSCLEROTIC LESION DEVELOPMENT; PROLIFERATOR-ACTIVATED RECEPTORS; RANDOMIZED CONTROLLED-TRIAL; MARROW-DERIVED CELLS;
D O I
10.1186/1743-7075-9-25
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Plasma levels of high density lipoprotein (HDL) cholesterol are strongly inversely correlated to the risk of atherosclerotic cardiovascular disease. A major recognized functional property of HDL particles is to elicit cholesterol efflux and consequently mediate reverse cholesterol transport (RCT). The recent introduction of a surrogate method aiming at determining specifically RCT from the macrophage compartment has facilitated research on the different components and pathways relevant for RCT. The current review provides a comprehensive overview of studies carried out on macrophage-specific RCT including a quick reference guide of available data. Knowledge and insights gained on the regulation of the RCT pathway are summarized. A discussion of methodological issues as well as of the respective relevance of specific pathways for RCT is also included.
引用
收藏
页数:18
相关论文
共 147 条
[1]   Influence of Apolipoprotein A-I Domain Structure on Macrophage Reverse Cholesterol Transport in Mice [J].
Alexander, Eric T. ;
Vedhachalam, Charulatha ;
Sankaranarayanan, Sandhya ;
de la Llera-Moya, Margarita ;
Rothblat, George H. ;
Rader, Daniel J. ;
Phillips, Michael C. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2011, 31 (02) :320-U217
[2]   Macrophage Reverse Cholesterol Transport in Mice Expressing ApoA-I Milano [J].
Alexander, Eric T. ;
Weibel, Ginny L. ;
Joshi, Michelle R. ;
Vedhachalam, Charulatha ;
de la Llera-Moya, Margarita ;
Rothblat, George H. ;
Phillips, Michael C. ;
Rader, Daniel J. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (10) :1496-U202
[3]   Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption [J].
Altmann, SW ;
Davis, HR ;
Zhu, LJ ;
Yao, XR ;
Hoos, LM ;
Tetzloff, G ;
Iyer, SPN ;
Maguire, M ;
Golovko, A ;
Zeng, M ;
Wang, LQ ;
Murgolo, N ;
Graziano, MP .
SCIENCE, 2004, 303 (5661) :1201-1204
[4]   5A Apolipoprotein Mimetic Peptide Promotes Cholesterol Efflux and Reduces Atherosclerosis in Mice [J].
Amar, Marcelo J. A. ;
D'Souza, Wilissa ;
Turner, Scott ;
Demosky, Stephen ;
Sviridov, Denis ;
Stonik, John ;
Luchoomun, Jayraz ;
Voogt, Jason ;
Hellerstein, Marc ;
Sviridov, Dmitri ;
Remaley, Alan T. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 334 (02) :634-641
[5]   Role of Hepatic Lipase and Endothelial Lipase in High-Density Lipoprotein-Mediated Reverse Cholesterol Transport [J].
Annema, Wijtske ;
Tietge, Uwe J. F. .
CURRENT ATHEROSCLEROSIS REPORTS, 2011, 13 (03) :257-265
[6]   Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A2 [J].
Annema, Wijtske ;
Nijstad, Niels ;
Toelle, Markus ;
de Boer, Jan Freark ;
Buijs, Ruben V. C. ;
Heeringa, Peter ;
van der Giet, Markus ;
Tietge, Uwe J. F. .
JOURNAL OF LIPID RESEARCH, 2010, 51 (04) :743-754
[7]   Haptoglobin genotype is a regulator of reverse cholesterol transport in diabetes in vitro and in vivo [J].
Asleh, Rabea ;
Miller-Lotan, Rachael ;
Aviram, Michael ;
Hayek, Tony ;
Yulish, Michael ;
Levy, Joanne E. ;
Miller, Benjamin ;
Blum, Shany ;
Milman, Uzi ;
Shapira, Chen ;
Levy, Andrew P. .
CIRCULATION RESEARCH, 2006, 99 (12) :1419-1425
[8]   High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport [J].
Assmann, G ;
Schulte, H ;
vonEckardstein, A ;
Huang, YD .
ATHEROSCLEROSIS, 1996, 124 :S11-S20
[9]   Is there a role for fibrates in the management of dyslipidemia in the metabolic syndrome? [J].
Barter, Philip J. ;
Rye, Kerry-Anne .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (01) :39-46
[10]   Cholesteryl ester transfer protein - A novel target for raising HDL and inhibiting atherosclerosis [J].
Barter, PJ ;
Brewer, HB ;
Chapman, MJ ;
Hennekens, CH ;
Rader, DJ ;
Tall, AR .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (02) :160-167